Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma
Abstract
This review aims at exploring nanoparticle-based phototherapies of uveal melanoma (UM), the most common primary intraocular malignancy in adults with an estimated incidence of 5-7 cases per million individuals per year, a disproportionately high metastatic risk and poor prognosis in advanced stages. UM exhibits unique biological and anatomical features, including an immune-privileged ocular microenvironment, the blood-ocular barrier, and high melanin content, contributing to therapeutic complexity. Current treatments, including radiotherapy, surgery, and systemic therapies, achieve local tumor control but remain limited by adverse effects, recurrence, and insufficient efficacy against metastatic disease. Laser-based therapies, including transpupillary thermotherapy and photodynamic therapy, offer minimally invasive alternatives. However, their performance is constrained by limited light penetration, melanin-induced uneven absorption, and incomplete tumor eradication. Recent advances in nanotechnology offer opportunities to overcome these limitations. Nanoparticle-based phototherapies can improve tumor targeting, photosensitizer delivery, and localized activation while reducing off-target effects. Multifunctional nanoplatforms may combine imaging, drug delivery, and synergistic therapies such as immunotherapy or chemotherapy. Although promising preclinical results highlight improved tumor control and antitumor responses, challenges related to safety, biodistribution, and clinical translation remain. This review discusses these challenges and future directions for optimized nanoplatforms to improve disease management and metastasis prevention.
Related
- A Novel Biocompatible Magnetic Nickel Nanoparticle-Based Nanocarrier for Potential Application in Promoting Plant Growth
- Nanotechnology integration in oncology for advanced nanoparticle based strategies in targeted cancer diagnosis and treatment
- Cryogenically Deposited Plasmonic Au Nanoparticle Films for Photothermal Treatment of Lung Cancer Cells
- Se@SiO2@mSiO2 nanoparticle inhibits cellular oxidative stress and Wnt/β-catenin pathway by inhibiting AGGF1 expression in the treatment of prostate cancer
- Unlocking the potential of silver-copper bimetallic nanoparticles: a review of recent advances, applications and future directions
BibTeX
@article{lambert2026potential,
title = {{Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma}},
author = {Emilie Lambert and Christophe Nguyen and Sean Edward Dunn and Magali Gary-Bobo and Jérôme Lacombe and Justin Moser and Frédéric Zenhausern and Jean‐olivier Durand and Frédérique Cunin},
journal = {Advanced Science},
year = {2026},
month = aug,
doi = {10.1002/advs.77396},
url = {https://hal.science/hal-05844405v1},
note = {CC BY},
}
RIS
TY - JOUR
TI - Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma
AU - Emilie Lambert
AU - Christophe Nguyen
AU - Sean Edward Dunn
AU - Magali Gary-Bobo
AU - Jérôme Lacombe
AU - Justin Moser
AU - Frédéric Zenhausern
AU - Jean‐olivier Durand
AU - Frédérique Cunin
PY - 2026
DA - 2026/08/31
JO - Advanced Science
DO - 10.1002/advs.77396
UR - https://hal.science/hal-05844405v1
AB - This review aims at exploring nanoparticle-based phototherapies of uveal melanoma (UM), the most common primary intraocular malignancy in adults with an estimated incidence of 5-7 cases per million individuals per year, a disproportionately high metastatic risk and poor prognosis in advanced stages. UM exhibits unique biological and anatomical features, including an immune-privileged ocular microenvironment, the blood-ocular barrier, and high melanin content, contributing to therapeutic complexity. Current treatments, including radiotherapy, surgery, and systemic therapies, achieve local tumor control but remain limited by adverse effects, recurrence, and insufficient efficacy against metastatic disease. Laser-based therapies, including transpupillary thermotherapy and photodynamic therapy, offer minimally invasive alternatives. However, their performance is constrained by limited light penetration, melanin-induced uneven absorption, and incomplete tumor eradication. Recent advances in nanotechnology offer opportunities to overcome these limitations. Nanoparticle-based phototherapies can improve tumor targeting, photosensitizer delivery, and localized activation while reducing off-target effects. Multifunctional nanoplatforms may combine imaging, drug delivery, and synergistic therapies such as immunotherapy or chemotherapy. Although promising preclinical results highlight improved tumor control and antitumor responses, challenges related to safety, biodistribution, and clinical translation remain. This review discusses these challenges and future directions for optimized nanoplatforms to improve disease management and metastasis prevention.
SN - 2198-3844
ER -